- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01700374
Happy Mommy! Happy Baby! Study (FAP)
Prepubertal Adversity Effect on Maternal Arousal, Preterm Birth and Infant Stress Response
The purpose of this study is to determine how difficult life-events that women experienced during their childhood might affect their babies.
Women who are asked to participate in this study will fill out forms about their physical and mental health, have 3D ultrasounds of their baby's adrenal gland, have their stress responses measured and have their baby's development and stress responses assessed.
Study Overview
Status
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Penn Center for Women's Behavioral Wellness
-
Philadelphia, Pennsylvania, United States, 19104
- 3701 Market Street
-
Philadelphia, Pennsylvania, United States, 19104
- Helen O. Dickens Center for Women's Health, Hospital of the University of Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19107
- Penn Medicine Washington Square (PMWS)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Women from the greater Philadelphia and surrounding areas who are ages 18 - 45 and between 8 and 17 weeks pregnant will be considered for enrollment into this study. All subjects must be physically healthy without a serious major medical illness, as well as be carrying a healthy fetus. Subjects will be recruited through fliers, advertising, and social media and may be directly approached at a University of Pennsylvania Health System (UPHS) or UPHS affiliated obstetrics and gynecology clinic. We anticipate the composition of the proposed study population to reflect the greater Philadelphia referral base. The projected composition from Philadelphia is African American 42.58%, Hispanic 8.5%, Asian 4.42%, Other 2.04% and White, not of Hispanic Origin, 42.46%.
Additionally, we plan to include father's of the babies that are willing and able to complete the ACE questionnaire.
Description
Inclusion Criteria:
- Aged 18 to 45 years;
- Able to give written informed consent;
- Between 8 to 17 weeks at time of recruitment;
- Attendance at 20 week ultrasound at a UPHS site;
- Healthy full term (35 6/7 weeks) infants;
- Fluency in written and spoken English.
Exclusion Criteria:
- Presence of a known abnormality in the present fetus, twin pregnancy or a multiple pregnancy;
- Presence of a serious medical or neurological illness, requiring treatment during pregnancy;
- Use of an antipsychotic or antidepressant medication anytime within 2 months prior to the last menstrual period;
- Drug or alcohol abuse history within previous 2 years;
- Life-time history of psychotic disorder including, schizophrenia, schizoaffective disorder; major depression with psychotic features and bipolar disorder
- Active psychiatric illness requiring treatment based upon the clinical judgement of the study psychiatrist;
- Hamilton Depression Rating Scale Score > 14;
- Suicidal ideation within the previous 6 months;
- Use of steroids drugs of antihypertensives during pregnancy as they could alter physiologic arousal;
- A history of preterm birth or history of preterm labor in the active pregnancy.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Women without Prepubertal Adversity
At 8-17 weeks gestational age, 1,500 pregnant women will complete:
All women who are screened will be asked if they would be willing to allow the study team to access their delivery report. Women who report 0 or 1 adverse childhood experiences will be invited to continue in the study as part of the Women without Prepubertal Adversity cohort. We aim to have 125 women in this cohort. |
|
Women with Prepubertal Adversity
At 8-17 weeks gestational age, 1,500 pregnant women will complete:
All women who are screened will be asked if they would be willing to allow the study team to access their delivery report. Women who report 2 or more adverse childhood experiences will be invited to continue in the study as part of the Women without Prepubertal Adversity cohort. We aim to have 125 women in this cohort. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fetal Adrenal Size
Time Frame: 20 to 22 weeks gestational age
|
The primary outcome variable is fetal adrenal size as measured by volume (ml) between 20 weeks and 22 weeks gestational age.
|
20 to 22 weeks gestational age
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physiologic Arousal
Time Frame: 15 to 21 weeks gestational age and 6 to 8 weeks postpartum
|
The secondary outcomes are physiologic arousal based on the maternal response to the acoustic startle paradigm or TSST plus salivary cortisol at 15-17 weeks gestational age and 6-8 weeks postpartum.
|
15 to 21 weeks gestational age and 6 to 8 weeks postpartum
|
|
Physiologic Arousal
Time Frame: 6 months postpartum
|
The secondary outcomes are physiologic arousal based on infant stress responses as measured by the infant behavioral assessment and salivary cortisol at 6 months postpartum.
|
6 months postpartum
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Cynthia N Epperson, M.D., University of Pennsylvania
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 812880
- P50MH099910 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress, Psychological
-
University of Thi-QarCompletedPsychological Stress | Academic StressIraq
-
Amsterdam UMC, location VUmcRigshospitalet, Denmark; Universitätsklinikum Hamburg-EppendorfNot yet recruitingStress | Stress and Burnout | Stress BiomarkersGermany, Denmark
-
New York State Psychiatric InstituteJohnson & JohnsonCompletedPsychological Stress in PregnancyUnited States
-
Hacettepe UniversityCompletedStressTurkey (Türkiye)
-
Baylor UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedAcute Psychological StressUnited States
-
Örebro University, SwedenCompletedPsychological Stress Due to SkydivingSweden
-
Universität Duisburg-EssenRecruitingStress | Burnout | Burnout Syndrome | Stress ResilienceGermany
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Amrita Vishwa VidyapeethamAmrita Viswa VidyapeethamCompletedCovid Related Psychological StressIndia
-
University of WashingtonNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not yet recruitingPsychological Stress | Social Interaction